First in Human Single Ascending Dose Study of MOR107
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03067363 |
|
Recruitment Status :
Terminated
(Part 1 completed successfully. Part 2 not conducted.)
First Posted : March 1, 2017
Last Update Posted : February 7, 2018
|
Sponsor:
Alan Richardson
Collaborator:
Quotient Clinical
Information provided by (Responsible Party):
Alan Richardson, LanthioPep BV
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | March 23, 2017 |
| Actual Study Completion Date : | March 23, 2017 |